설사형 과민성대장증후군 환자에 대한 저령차전자탕의 효과 2례
Two Case Reports of Patients with Diarrhea-predominant Irritable Bowel Syndrome Treated with Jeoreongchajeonja-tang
1
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study was to describe the effectiveness of Jeoreongchajeonja-tang as a treatment for patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Methods: Two irritable bowel syndrome patients who had visited Semyung University Korean Medical Hospital were enrolled. The patients were diagnosed according to the Rome III criteria, and the treatment effect was assessed using the Gastrointestinal Symptom Rating Scale (GSRS) and the colon transit time. Results: After treatment with Jeoreongchajeonja-tang for 4 weeks, the GSRS score was improved and colon transit time was delayed. Conclusions: This study suggests that Jeoreongchajeonja-tang is effective for improving diarrhea-predominant irritable bowel syndrome. More extensive study is needed in the future.
Abstract
Objectives: The purpose of this study was to describe the effectiveness of Jeoreongchajeonja-tang as a treatment for patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Methods: Two irritable bowel syndrome patients who had visited Semyung University Korean Medical Hospital were enrolled. The patients were diagnosed according to the Rome III criteria, and the treatment effect was assessed using the Gastrointestinal Symptom Rating Scale (GSRS) and the colon transit time. Results: After treatment with Jeoreongchajeonja-tang for 4 weeks, the GSRS score was improved and colon transit time was delayed. Conclusions: This study suggests that Jeoreongchajeonja-tang is effective for improving diarrhea-predominant irritable bowel syndrome. More extensive study is needed in the future.
참고문헌 (18)
- Lee YW, "Analysis of Case Reports for Korean medical treatment of Irritable Bowel Syndrome", Journal of Haehwa Medicine, 25(1), pp.87~97 (2016)
- El-Serag HB, "Health-related quality of life among persons with irritable bowel syndrome : a systematic review", Aliment Pharmacol Ther, 16(6), pp.1171~1185 (2002)
- 권중구, "과민성 장증후군 치료에 관한 임상진료지침", 대한소화기학회지, 57(2), pp.82~99 (2011), 대한소화기학회
- 김현정, "로마 기준 IV 이해하기: 과민성 장증후군과 기능성 설사", 대한내과학회지, 92(4), pp.366~371 (2017), 대한내과학회[DOI]
- 윤종민, "설사형 과민성 장 증후군 치험례", 동의생리병리학회지, 18(6), pp.1913~1917 (2004), 한의병리학회
- Chey WD, "Irritable bowel syndrome : a clinical review", JAMA, 313(9), pp.949~958 (2015)
- Drossman DA, "Rome IV-functional GI disorders : disorders of gut-brain interaction", Gastroenterology, 150(6), pp.1257~1261 (2016)
- 권용환, "과민성장증후군과 연관된 중개연구 현황", 대한소화기학회지, 68(3), pp.138~142 (2016), 대한소화기학회
- 김정환, "과민성장증후군 치료전략: 언제, 어떤 약을 사용할 것인가?", 대한내과학회지, 86(6), pp.695~697 (2014), 대한내과학회[DOI]
- Hookway C, "Irritable bowel syndrome in adults in primary care : summary of updated NICE guidance", BMJ, 350, pp.h701~ (2015)
- 김현진, "FODMAP이란?", 대한내과학회지, 89(2), pp.179~185 (2015), 대한내과학회[DOI]
- Ha SK, "One of case is irritable bowel syndrome patient have treated with moxibustion", The society of Korean oriental internal medicine, (2), pp.230~237 (2003)
- Oh R, "Review on the Mechanism and Differential Diagnosis of Diarrhea", Korean Journal of Oriental Physiology & Pathology, 13(1), pp.47~58 (1999)
- 박은아, "少陽人 亡陰證 환자의 治驗 2례", 사상체질의학회지, 18(3), pp.210~215 (2006), 사상체질의학회
- 장순우, "고지방식이로 유도된 비만 생쥐모델에서 저령차전자탕의 항비만 효과", 사상체질의학회지, 30(2), pp.8~27 (2018), 사상체질의학회[DOI]
- 임현주, "화병변증도구 개발 연구", 동의생리병리학회지, 22(5), pp.1071~1077 (2008), 한의병리학회
- Wiklund IK, "An irritable bowel syndrome specific symptom questionnaire : Development and validation", Scand J Gastroenterol, 38(9), pp.947~954 (2003)
- Park HJ, "Comparison of 4-day and 7-day Methods in the Evaluation of Colon Transit Time", The Korean Journal of Gastroenterolgy, 38(4), pp.241~246 (2001)